The Diverse Spectrum of Invasive Meningococcal Disease in Pediatric and Adolescent Patients: Narrative Review of Cases and Case Series Shravani BobdeWoo-Yun SohnNelly Ninis Review Open access 29 January 2024 Pages: 251 - 271
A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States Jennifer EeuwijkGui FerreiraMirna Robert-Du Ry van Beest Holle Review Open access 13 February 2024 Pages: 273 - 298
Comparative Analysis of Outpatient Antibiotic Prescribing in Early Life: A Population-Based Study Across Birth Cohorts in Denmark and Germany Oliver ScholleLotte RasmussenUlrike Haug Original Research Open access 23 January 2024 Pages: 299 - 312
Impact of Invasive Escherichia Coli Disease on Clinical Outcomes and Medical Resource Utilization Among Asian Patients in the United States Chao ZhuoBo ZhengYoshiaki Gu Original Research Open access 24 January 2024 Pages: 313 - 328
Clinical Characteristics of Lung Consolidation with Mycoplasma pneumoniae Pneumonia and Risk Factors for Mycoplasma pneumoniae Necrotizing Pneumonia in Children Xue ZhangRuiyang SunChunlan Song Original Research Open access 24 January 2024 Pages: 329 - 343
Letermovir Effectively Prevents Cytomegalovirus Infection in Patients with Aplastic Anemia After Hematopoietic Stem Cell Transplantation: A Real-World Retrospective Cohort Study Yuling ZhangXiaowei ChenShunqing Wang Original Research Open access 24 January 2024 Pages: 345 - 359
First-in-Human Safety, Tolerability, and Pharmacokinetics of Single-Dose Kukoamine B Mesylate in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase I Study Hongzhong LiuQian ZhaoPei Hu Original Research Open access 30 January 2024 Pages: 361 - 371
Association Between Risk of Clostridium difficile Infection and Duration of Proton Pump Inhibitor or H2-Receptor Antagonist Use in Hospitalized Patients Chien-Huei HuangYung-Hsin TsengYi-Hsuan Liu Original Research Open access 30 January 2024 Pages: 373 - 383
Epidemiology of Pertussis and Pertussis-Related Complications in Adults: A German Claims Data Analysis Bastian SurmannJulian WittePavo Marijic Original Research Open access 31 January 2024 Pages: 385 - 399
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial Russell M. NicholsLisa MacphersonAmanda Peppercorn Brief Report Open access 30 January 2024 Pages: 401 - 411